Should We Consider Recombinant Human Brain Natriuretic Peptide to Prevent Postoperative Atrial Fibrillation?
- PMID: 36214698
- DOI: 10.1097/FJC.0000000000001375
Should We Consider Recombinant Human Brain Natriuretic Peptide to Prevent Postoperative Atrial Fibrillation?
Conflict of interest statement
G. Biondi-Zoccai has consulted for Cardionovum, CrannMedical, Innovheart, Meditrial, Opsens Medical, Replycare, Teleflex, and Terumo. The remaining authors report no conflicts of interest.
References
-
- Dobrev D, Aguilar M, Heijman J, et al. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol. 2019;16:417–436.
-
- Greenberg JW, Lancaster TS, Schuessler RB, et al. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg. 2017;52:665–672.
-
- Kalra R, Parcha V, Patel N, et al. Implications of atrial fibrillation among patients with atherosclerotic cardiovascular disease undergoing noncardiac surgery. Am J Cardiol. 2020;125:1836–1844.
-
- Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135:1061–1073.
-
- Greenberg JW, Lancaster TS, Schuessler RB, et al. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg. 2017;52:665–672.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
